How to accelerate oncology clinical trials through site relationships and patient insights
Learn how all stakeholders benefit when patients and their insights are at the heart of every aspect of clinical development.
Read More
Latest Biotech Content
Solutions and resources to accelerate, guide and simplify your drug development journey.
-
-
Loading, please wait
Error - something went wrong!
Let's start a conversation...
Thank you! We'll be in touch soon.
-
Four Keys to a Smoother Clinical Development Journey
Whitepaper recently published in Fierce Biotech providing perspectives on how the right partner can help bring all the disciplines together for a successful development program.
Read More
-
Multi-stakeholder strategies for external control arms
New ways of thinking are needed about vast sources of data amassed — and how that data can be fit-for-purpose to meet drug approval and access standards.
Read More
-
How a joined-up development strategy pays off for early-stage biotechs
Parexel Biotech’s Nate Akers, VP, Business Development, and Vicky Hsu, Head of Operations in Asia discuss the importance of aligning clinical execution with a clearly defined regulatory strategy.
Read More
-
Decentralized Trials: Considerations for Building a New Patient-Centric Model
Graciela Racaro, Global Head of Operations for Parexel Biotech, discusses the advances we have seen in the past year towards a more patient-centric environment.
Learn More
- Get the eBook
-
Jim Anthony: A personal connection to driving great medicine in the future
Jim Anthony, Global Head of Parexel Biotech, describes how losing his father to an incurable disease and his early experiences in science and business led him to his role helping biotech companies.
Watch Video
-
Graciela Racaro: A personal connection to driving great medicine in the future
Graciela Rácaro, Global Head of Operations for Parexel Biotech, discusses how she has had to change the course of her career direction multiple times on the way to meeting her ultimate goal.
Watch Video
-
Ubavka DeNoble: Helping our customers in moments that matter
Ubavka DeNoble, Senior Medical Officer for Parexel Biotech, shares how her experiences taught her the power of adapting and persevering against long odds that’s shared by everyone at Parexel Biotech.
Watch Video
-
Skip Sands: Helping our customers in moments that matter
Skip Sands, Senior Medical Officer for Parexel Biotech, explains how his family history, his career in medicine, and his experience with inadequate medical care inspire him.
Watch Video
-
Parexel Biotech Brochure
Learn about the services and approaches that Parexel Biotech offers to help you make an exponential difference in patients’ lives.
Read More
-
Tips for building your oncology reimbursement strategy
In this infographic, we share five tips for building an effective reimbursement strategy for your oncology product.
Learn More
-
Our latest Cell & Gene Therapy content, all in one place
See more -
Decentralized clinical trials - A more patient-centric approach
Decentralized clinical trials, where portions of a study are conducted outside a traditional trial site, offer new opportunities — and new hope — for patients struggling with inflammatory conditions.
Read More
- Get the eBook
-
Guide for Real-World Evidence
Parexel Biotech has created this guide to simplify the nomenclature and types of real-world studies.
Read More
-
Entering a new age of evidence generation: synthetic control models
Expert perspectives from Parexel's Leanne Larson, Senior Vice President and WW Head of Real-World Evidence
Read More
-
Crafting an early genomics strategy in oncology drug development
Discover three key considerations for crafting a successful genomic biomarker strategy in this article.
Read More
-
Top ten rules for success in decentralized trials
In this article, we summarize what we’ve learned and outline the top 10 rules for a successful DCT.
Read More
-
Five competencies for operational excellence in cell and gene therapy clinical trials
What is different about cell & gene therapy trials, and what does it take to operationalize them effectively? We break it down into five competencies you need for success.
Read More
-
How RWE can help Biotechs optimize the value of their asset
Matthew Gordon, VP of Real-World Evidence Strategy, Parexel, and Jimmy Brown, VP, Parexel Biotech discuss how RWE is a tremendously versatile tool for biotech companies at all stages.
Read More
-
PharmaVOICE - The RWE Evolution
What the industry is currently experiencing is an evolution of processes founded in solid science and good clinical study practices.
Read More
-
Battling rare disease: personally and professionally
Lisa Dilworth – VP of Operations for Parexel Biotech Americas West, and Sarah Glass – Global Head of Rare Diseases for Parexel, share candidly about their personal journeys with rare diseases.
Watch Video
-
Loading More...
